Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin prophylaxis in advanced HIV disease
NCT05580666Phase 3Recruiting
- Sponsor
- Population Health Research Institute
- Start
- May 2023
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of azithromycin in human immunodeficiency virus infection (HIV), sponsored by Population Health Research Institute. Started May 2023; status: recruiting.
02
Drugs
azithromycin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05580666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05580666.